9:55 am - 10:25 am 
IBD

Keynote Address:
Pushing Boundaries: What to do when the dose on the label fails

Objectives:

1. How to manage IBD when standard dosing fails​

2. Understanding what type of dose optimization strategies are safe and effective 

3. Where clinical trials fit in the management of the refractory patient

Mark S. Silverberg MD, PhD, FRCPC is a Professor in the Department of Medicine at the University of Toronto and an attending gastroenterologist at Mount Sinai with a focus on the management of complicated IBD. He runs a research laboratory studying biomarkers relevant to its clinical course. Dr. Silverberg is actively engaged in educating health care professionals on IBD through his roles as Founder and Past Director of the Advanced IBD Fellowship Program at Mount Sinai, and co-director of both the Canadian GI Fellows Program in IBD and the Great Lakes IBD Forum. He is an elected member of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) and Past Chair of the IMIBD Section of the American Gastroenterological Association (AGA) Council. He is Founder of the Toronto Immune and Digestive Health Institute (TIDHI), a unique stand-alone facility providing multi-disciplinary digestive disease care in a community clinic setting.